To the Editor: Grillo et al. reviewed the use of rapid infusion of IV immune globulin in patients with neuromuscular disorders.1 Their abstract and discussion claim the safety and convenience of this practice in their population of patients, and the final sentence of their abstract states: “Rapid infusion IVIg can be …
No takes yet. Share an insight, caveat, or question.
Gomperts et al. (2002) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: